HCA Healthcare, Inc. HCA

Healthcare SIC 8062 - Services-General Medical & Surgical Hospitals, NEC NYSE

HCA Healthcare, Inc. is one of the leading health care services companies in the United States. At December 31, 2025, we operated 190 hospitals, comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. In addition, we operated 121 freestanding ambulatory surgery centers ("ASCs") and 31 freestanding endoscopy centers. Our facilities are located in 19 states and England.

Our primary objective is to provide a comprehensive array of quality health care services in the most cost-effective manner possible. Our general, acute care hospitals typically provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by our general, acute care hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic centers, home health agencies, hospices and rehabilitation facilities and various other facilities. Our behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings.

Last close 405.00 2026-09-04
Market cap $89.85B 2026-03-31 share count
52-week range 353.99 - 556.52

Valuation FY2025 figures against the last close

P/S1.2x
P/E14.3x
P/FCF11.7x
EV/EBITDA
Dividend yield0.8%
Diluted EPS28.33

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
SG&A $548.0M$421.0M$353.0M$307.0M$337.0M$416.0M$370.0M$344.0M$340.0M$343.0M
Total operating expenses $65.77B$62.08B$57.26B$51.65B$48.92B$46.10B$46.09B$41.34B$39.23B$36.68B
Interest expense $2.25B$2.06B$1.94B$1.74B$1.57B$1.58B$1.82B$1.75B$1.69B$1.71B
Pre-tax income $9.83B$8.52B$7.71B$8.58B$9.83B$5.43B$5.24B$5.33B$4.38B$4.81B
Income tax $2.05B$1.87B$1.61B$1.75B$2.11B$1.04B$1.10B$946.0M$1.64B$1.38B
Net income $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
EPS, basic 28.7022.2719.2519.4321.5211.1010.2710.906.127.53
EPS, diluted 28.3322.0018.9719.1521.1610.9310.0710.665.957.30
Shares, diluted (wtd. avg.) $239.5M$261.8M$276.4M$294.7M$328.8M$343.6M$348.2M$355.3M$372.2M$395.9M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $1.04B$1.93B$935.0M$908.0M$1.45B$1.79B$621.0M$502.0M$732.0M$646.0M
Short-term investments $103.0M$116.0M
Receivables $10.87B$10.75B$9.96B$8.89B$8.10B$7.05B$7.38B$6.79B$6.50B$5.83B
Inventory $1.65B$1.74B$2.02B$2.07B$1.99B$2.02B$1.85B$1.73B$1.57B$1.50B
Total current assets $15.78B$16.41B$14.93B$13.64B$13.54B$12.33B$11.20B$10.21B$9.98B$9.09B
Property, plant and equipment $31.14B$29.41B$27.71B$25.57B$24.06B$23.20B$22.71B$19.76B$17.89B$16.35B
Total assets $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Accounts payable $4.66B$4.28B$4.23B$4.24B$4.11B$3.54B$2.90B$2.58B$2.61B$2.32B
Short-term debt $4.89B$4.70B$2.42B$370.0M$237.0M$209.0M$145.0M$788.0M$200.0M$216.0M
Total current liabilities $16.35B$15.18B$12.65B$9.90B$9.58B$8.70B$7.76B$7.57B$6.16B$5.83B
Long-term debt $41.60B$38.33B$37.17B$37.71B$34.34B$30.80B$33.58B$32.03B$32.86B$31.16B
Total liabilities $45.62B$42.12B$41.59B$39.39B
Retained earnings -$5.72B-$2.12B-$1.35B-$2.28B-$532.0M$777.0M-$2.35B-$4.57B-$6.53B-$6.97B
Total equity -$6.03B-$2.50B$1.06B-$73.0M$1.49B$2.89B-$565.0M-$2.92B-$5.00B-$5.63B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $12.64B$10.51B$9.43B$8.52B$8.96B$9.23B$7.60B$6.76B$5.43B$5.65B
Depreciation and amortisation $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Stock-based compensation $401.0M$360.0M$262.0M$341.0M$440.0M$362.0M$347.0M$268.0M$270.0M$251.0M
Capital expenditure $4.94B$4.88B$4.74B$4.39B$3.58B$2.83B$4.16B$3.57B$3.02B$2.76B
Investing cash flow -$4.99B-$4.93B-$5.32B-$3.39B-$2.64B-$3.39B-$5.72B-$3.90B-$4.28B-$3.24B
Financing cash flow -$8.55B-$4.58B-$4.09B-$5.66B-$6.66B-$4.68B-$1.77B-$3.08B-$1.06B-$2.51B
Dividends paid $679.0M$690.0M$661.0M$653.0M$624.0M$153.0M$550.0M$487.0M$0
Buybacks $10.07B$6.04B$3.81B$7.00B$8.21B$441.0M$1.03B$1.53B$2.05B$2.75B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-044769.

Others in SIC 8062

TickerCompanyMarket capP/ERevenue growth
THC TENET HEALTHCARE CORP $21.34B 17.1x 3.1%
UHS UNIVERSAL HEALTH SERVICES INC $10.12B 7.3x 9.7%
SGRY Surgery Partners, Inc. $1.87B 6.2%
ARDT Ardent Health, Inc. $1.54B 11.4x 6.0%
CYH COMMUNITY HEALTH SYSTEMS INC $407.5M 0.8x -1.2%